Inactive Instrument

PERRIGO Share Price TEL AVIV STOCK EXCHANGE

Equities

Pharmaceuticals

End-of-day quote TEL AVIV STOCK EXCHANGE
- ILa - Intraday chart for PERRIGO

Financials

Sales 2024 * 461.98Cr 1,72700Cr 39TCr Sales 2025 * 483.01Cr 1,80500Cr 40TCr Capitalization 357.02Cr 1,33400Cr 30TCr
Net income 2024 * -7.3Cr -2.73TCr -609.46Cr Net income 2025 * 11Cr 3.96TCr 884.97Cr EV / Sales 2024 * 1.47 x
Net Debt 2024 * 320.86Cr 1,19900Cr 27TCr Net Debt 2025 * 301.2Cr 1,12600Cr 25TCr EV / Sales 2025 * 1.36 x
P/E ratio 2024 *
-18.1 x
P/E ratio 2025 *
164 x
Employees -
Yield 2024 *
4.21%
Yield 2025 *
4.48%
Free-Float 99.66%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 55 30/23/30
Director of Finance/CFO 49 16/22/16
Chief Tech/Sci/R&D Officer - 01/15/01
Members of the board TitleAgeSince
Chairman 55 15/20/15
Director/Board Member 68 06/17/06
Director/Board Member 67 06/17/06
More insiders
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
More about the company